Drugs, leads, and drug-likeness: an analysis of some recently launched drugs.

[1]  Eugen Reichel,et al.  1. A - C , 1909 .

[2]  S. Cohen,et al.  A new probe for heterogeneity in muscarinic receptors: 2-methyl-spiro-(1, 3-dioxolane-4, 3')-quinuclidine. , 1976, European journal of pharmacology.

[3]  H. Hofmeister,et al.  Synthesis of Spirorenone—A Novel Highly Active Aldosterone Antagonist , 1982 .

[4]  T. Mori,et al.  Synthetic studies of vitamin D3 analogues. VIII. Synthesis of 22-oxavitamin D3 analogues. , 1986, Chemical & pharmaceutical bulletin.

[5]  J. Flippen-Anderson,et al.  Arteether, a new antimalarial drug: synthesis and antimalarial properties. , 1988, Journal of medicinal chemistry.

[6]  D W Cushman,et al.  Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines. , 1988, Journal of medicinal chemistry.

[7]  P. Lombardi,et al.  6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): a new irreversible aromatase inhibitor. , 1988, Journal of steroid biochemistry.

[8]  M. Yasunami,et al.  Synthesis and anti-ulcer activities of sodium alkylazulene sulfonates. , 1988, Chemical & pharmaceutical bulletin.

[9]  K. Iwata,et al.  In vitro and in vivo activities of piritetrate (M-732), a new antidermatophytic thiocarbamate , 1989, Antimicrobial Agents and Chemotherapy.

[10]  M Gwilt,et al.  Selective class III antiarrhythmic agents. 1 Bis(arylalkyl)amines. , 1990, Journal of medicinal chemistry.

[11]  H. Sugano,et al.  Synthesis and central nervous system actions of thyrotropin-releasing hormone analogues containing a dihydroorotic acid moiety. , 1990, Journal of medicinal chemistry.

[12]  Aalt Bast,et al.  Comprehensive medicinal chemistry , 1991 .

[13]  Anne W. Schmidt,et al.  1-Naphthylpiperazine derivatives as potential atypical antipsychotic agents. , 1991, Journal of medicinal chemistry.

[14]  D. Gurwitz,et al.  (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease. , 1991, The Journal of pharmacology and experimental therapeutics.

[15]  J. Gobert,et al.  ucb L059, a novel anti-convulsant drug: pharmacological profile in animals. , 1992, European journal of pharmacology.

[16]  A. Brown,et al.  (+/-) 3-Amino-6-carboxamido-1,2,3,4-tetrahydrocarbazole: a conformationally restricted analogue of 5-carboxamidotryptamine with selectivity for the serotonin 5-HT1D receptor. , 1993, Journal of medicinal chemistry.

[17]  H. Ohnishi,et al.  Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs. , 1993, European journal of pharmacology.

[18]  D. Mangelsdorf,et al.  Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties. , 1994, Journal of medicinal chemistry.

[19]  K. Jaeggi,et al.  Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  N. Kalkkinen,et al.  Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study. , 1994, The Journal of biological chemistry.

[21]  L Zhang,et al.  Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids. , 1994, Journal of medicinal chemistry.

[22]  M. Yoshigi,et al.  Succinimide derivatives. II. Synthesis and antipsychotic activity of N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-1,2-cis- cyclohexanedicarboximide (SM-9018) and related compounds. , 1995, Chemical & pharmaceutical bulletin.

[23]  S. J. Brickner,et al.  Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. , 1996, Journal of medicinal chemistry.

[24]  Anne W. Schmidt,et al.  3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents. , 1996, Journal of medicinal chemistry.

[25]  Ajay,et al.  Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? , 1998, Journal of medicinal chemistry.

[26]  Dale J. Kempf,et al.  ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus Protease , 1998, Antimicrobial Agents and Chemotherapy.

[27]  H. Kubinyi,et al.  A scoring scheme for discriminating between drugs and nondrugs. , 1998, Journal of medicinal chemistry.

[28]  G. Bemis,et al.  Properties of known drugs. 2. Side chains. , 1999, Journal of medicinal chemistry.

[29]  Tudor I. Oprea,et al.  The Design of Leadlike Combinatorial Libraries. , 1999, Angewandte Chemie.

[30]  J. Palacios,et al.  Pharmacological characterization of almotriptan: an indolic 5-HT receptor agonist for the treatment of migraine. , 2000, European journal of pharmacology.

[31]  Pickett,et al.  Computational methods for the prediction of 'drug-likeness' , 2000, Drug discovery today.

[32]  Tudor I. Oprea,et al.  Is There a Difference between Leads and Drugs? A Historical Perspective , 2001, J. Chem. Inf. Comput. Sci..

[33]  I. Muegge,et al.  Simple selection criteria for drug-like chemical matter. , 2001, Journal of medicinal chemistry.